Skip to content

Alite AVE003

by Revelle Aesthetics, Inc.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source GUDID, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00850036790020 UDI-DI Date1 Sep 2025ListedStatusListed GUDID: in commercial distribution

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade Name
Alite
Generic Name
Subcutaneous infusion transilluminator
Model / Reference
AVE003
Primary DI / UDI-DI
00850036790020
FDA Product Code
FTD
GMDN Term
Subcutaneous infusion transilluminator
Device Class
Class II
Regulation Number
878.4580
GUDID distribution status
In Commercial Distribution

Other devices from Revelle Aesthetics, Inc.

  • Aveli AVE002

    Class II
  • Aveli AVE001

    Class I
  • Avéli

    Class II
  • Avéli

    Class II

Properties

  • Sterile
  • Single Use
  • Prescription Use
  • Premarket Exempt
  • Lot / Batch Number
  • Serial Number
  • Expiration Date
  • Manufacturing Date

Other properties (6)

  • Implantable: No
  • Contains Latex: No
  • Over-the-Counter: No
  • Convenience Kit: No
  • Combination Product: No
  • HCT/P: No